Avantax Planning Partners’s Idexx Laboratories IDXX Stock Holding History

Avantax Planning Partners’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-55	Closed	-$11K	–	797
2018 Q1	$11K	Buy	+55	New	+$10.2K	﹤0.01%	996

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FEF

Fundsmith Equity Fund Stamford, Connecticut $13.4B AUM

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Avantax Planning Partners's IDXX Position: Q2 2018 in Review

Avantax Planning Partners sold out of Idexx Laboratories (IDXX) in Q2 2018, closing a stake of 55 shares — an estimated $11K sold.

Avantax Planning Partners first reported a position in IDXX in Q1 2018 and held it in 1 quarter. The position peaked at $11K in Q1 2018. 664 funds tracked by Wall St. Rank hold IDXX as of Q2 2018.

Avantax Planning Partners reported no remaining Idexx Laboratories position as of Q2 2018 after selling out during the quarter.
Avantax Planning Partners sold 55 Idexx Laboratories shares in Q2 2018, an estimated $11K.
Avantax Planning Partners first reported a position in Idexx Laboratories in Q1 2018 and held it in 1 quarter.
Avantax Planning Partners's Idexx Laboratories position peaked at $11K in Q1 2018.
664 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2018.

Based on Avantax Planning Partners's 13F filing for Q2 2018, filed 13 Aug 2018.